Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.57 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.57 |
| ▸ | TERT | O14746 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | FABP4 | P15090 | 2/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16600174 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL7065131 | 1.00 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL20215371 | 0.98 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL11545687 | 0.98 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL11545683 | 0.98 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL4242272 | 0.98 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL28188747 | 0.98 | L3MBTL1 (0.77) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL31329282 | 0.95 | L3MBTL1 (0.70) | L3MBTL1KMT2AMEN1TDP1HSD17B10 | |
| SCHEMBL7064209 | 0.93 | GNAI3 (0.65) | L3MBTL1KMT2AMEN1TDP1GNAI3 | |
| SCHEMBL9016893 | 0.93 | GNAI3 (0.65) | L3MBTL1KMT2AMEN1TDP1GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160242443-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2016-08-25 | — | — | US | claimed |
| EP-3057448-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | claimed |
| WO-2015050534-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | claimed |
| US-11807745-B2 | Interior automotive part | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-11-07 | — | — | US | disclosed |
| EP-3559109-B1 | INTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-03-15 | — | — | EP | disclosed |
| US-10674755-B2 | Organic Compounds | GIVAUDAN S.A. (CH) | 2020-06-09 | — | — | US | disclosed |
| US-20200102449-A1 | INTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-04-02 | — | — | US | disclosed |
| EP-3559110-A1 | EXTERIOR OR SEMI-EXTERIOR AUTOMOTIVE PART | SABIC Global Technologies B.V. (NL) | 2019-10-30 | — | — | EP | disclosed |
| EP-3559109-A1 | INTERIOR AUTOMOTIVE PART | SABIC Global Technologies B.V. (NL) | 2019-10-30 | — | — | EP | disclosed |
| US-20190322851-A1 | EXTERIOR OR SEMI-EXTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-10-24 | — | — | US | disclosed |
| WO-2018114979-A1 | INTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018114984-A1 | EXTERIOR OR SEMI-EXTERIOR AUTOMOTIVE PART | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-06-28 | — | — | WO | disclosed |
| EP-3057448-B1 | ORGANIC COMPOUNDS HAVING TASTE-MODIFYING PROPERTIES | GIVAUDAN SA (CH) | 2017-12-06 | — | — | EP | disclosed |
| US-20160242443-A1 | Organic Compounds | GIVAUDAN S.A. (CH) | 2016-08-25 | — | — | US | disclosed |
| EP-3057448-A1 | ORGANIC COMPOUNDS | Givaudan S.A. (CH) | 2016-08-24 | — | — | EP | disclosed |
| WO-2015050534-A1 | ORGANIC COMPOUNDS | GIVAUDAN S.A. (CH) | 2015-04-09 | — | — | WO | disclosed |
| US-20030036592-A1 | Novel slip agents and polypropylene films prepared therefrom | APPLIED EXTRUSION TECHNOLOGIES, INC. | 2003-02-20 | — | — | US | disclosed |
| US-6497965-B1 | PRINTING PLATES COMPRISING POLYOLEFINS, ETHYLENE-PROPYLENE COPOLYMER BLOCKING LAYERS AND N,N'-BIS-ETHYLENE OLEAMIDE OR BEHENAMIDE SLIDING AGENTS TO REDUCE FRICTION; GRAVURE | APPLIED EXTRUSION TECHNOLOGIES, INC. | 2002-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10674755-B2 | Organic Compounds | C9, PRMT5, CBR3 | L3MBTL1 1080/4885KMT2A 1785/4885MEN1 3493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.